MaxCyte On-Demand Live Seminars
Unlock Insights into Cutting-Edge Cell Engineering with Live Seminars
Explore the forefront of cell therapy, bioprocessing and non-viral gene editing with MaxCyte’s online or on-site live seminars. Designed for scientists, researchers and industry professionals, these free events dive deep into electroporation advancements, GMP-compliant solutions and the transformative power of Flow Electroporation® technology. Backed by proven data, our technology demonstrates success with a wide variety of cell types and applications, offering scalability from early research and clinical phases to commercial manufacturing for cell therapies.
Why schedule a seminar?
MaxCyte’s seminars are tailored to empower your team with actionable knowledge, featuring:
- Expert-Led Discussions: Gain insights from experienced scientists and industry leaders.
- Broad Applications: Learn how MaxCyte’s Flow Electroporation® technology is used across a broad range of applications in cell therapy development, protein production and cell-based assays.
- Scalability Solutions: Explore workflows from small-scale research to large-scale commercial manufacturing.
- Proven Results: See real-world case studies highlighting successful non-viral transfections and GMP-compliant processes.
Select the ideal seminar for your goals:
Gene Editing
Gene Editing has tremendous potential as a therapeutic tool for treating human diseases. However, prolonged expression of the nuclease and gRNA using viral vectors may cause unwanted off-target effects and potential immunogenicity in vivo. To overcome these safety concerns, the MaxCyte electroporation platform was developed for transient delivery of gene editing tools.
The MaxCyte platform can enable efficient and scalable gene editing for knock-out, knock-in and deletions, utilizing tools such as:
- CRISPR/Cas9
- Zinc Finger Nucleases
- Base Editors
- Prime Editors
- Novel Nucleases
Protein Production
Our platforms can be leveraged for applications such as antibody production, cell line development and recombinant protein production.
This includes:
- High Performance CHO and HEK293 transfection allows transient production in a manufacturing cell background
- Gram-Scale production sufficient for later stage development
- MaxCyte's technology shortens timeline for stable pool and cell line generation
- High performance produces faster cell recovery and allows strong selection pressure
Cell Therapy Production
MaxCyte's ExPERT clinically validated, scalable electroporation platform can be used in pre-clinical and clinical scale engineering of cell therapy products. It's a flexible technology platform that can enable the next-generation of autologous and allogeneic non-viral primary cell therapies, creating off-the-shelf modalities with the potential for enhanced effectiveness for refractory cancer.
This includes applications such as:
- Using a mesothelin targeting CAR mRNA
- Enhancement of NK cell cytotoxicities against B cell malignancies using an anti-CD19 CAR mRNA
- Transposon (PiggyBac, Sleeping Beauty, etc.) based gene delivery for manufacturing of CAR T and CAR NK cell therapies
- Gene editing of T cells for improving the efficacy of a TCR immunotherapy
Custom Seminar
Want a customized seminar for your lab? Happy to help!
Let's build a customized seminar just for your team.
We will tailor our content so we can answer all your questions.
